Etodolac Prolonged Release Tablets IP 400 Mg – TORODEL 400 ER
Composition – Etodolac Extended Release 400 mg.
Description:
The composition of Etodolac Prolonged Release Tablets IP 400 Mg is a nonsteroidal anti-inflammatory drug (NSAID) that works by selectively inhibiting cyclooxygenase-2 (COX-2), reducing the production of prostaglandins responsible for pain and inflammation. The extended-release formulation provides long-lasting therapeutic effects, making it ideal for conditions requiring consistent pain management. Its balanced COX-1 sparing action minimizes the risk of gastrointestinal irritation commonly associated with NSAIDs.
Key Benefits:
• Prolonged Relief: Extended-release formulation ensures sustained pain and inflammation control throughout the day, reducing the need for frequent dosing.
• Selective COX-2 Inhibition: Provides effective anti-inflammatory and analgesic effects with a reduced risk of gastrointestinal side effects compared to traditional NSAIDs.
• Versatile Use : Effectively manages acute and chronic pain, including osteoarthritis, rheumatoid arthritis, and post-surgical inflammation.
Targeted specalists:
• Orthopedician
• General Physician
• Rheumatologist
Disclaimer
To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion









